Funding news
OpenObserve logo

OpenObserve Raises $3.6M Seed Round to

Recently funded · $3.6M SeedGovernment AdministrationUS

Get the full OpenObserve company profile

Access contacts, investors, buying signals & more

Open in Dashboard

OpenObserve has secured $3.6 million in investment capital from investors. The company provides a unified platform designed to consolidate logs, metrics, and traces, directly addressing the common challenge teams face in managing complex and expensive observability stacks. OpenObserve aims to offer a streamlined and cost-effective alternative to traditional solutions like Elasticsearch, Splunk, Datadog, and Grafana, which can often become overly costly or difficult to operate at scale.

The platform distinguishes itself by offering significant operational efficiencies and cost savings. It provides 4x lower compute and 140x lower storage costs compared to Elasticsearch, coupled with faster query and ingestion performance. OpenObserve is engineered in Rust for high performance without constant tuning, supports native OpenTelemetry, and is compatible with S3 storage. Deployed in production by thousands of companies, it offers a single binary for quick starts and Kubernetes-based high availability for production workloads, with flexible self-hosted or cloud deployment options and migration guides for major platforms.

This new funding round will enable OpenObserve to accelerate its product development roadmap and expand its market reach. The company plans to strategically deploy the capital to further enhance its platform's capabilities, scale its operations to meet growing demand, and continue its mission of simplifying observability. OpenObserve is positioned to continue its growth trajectory, providing teams with a more efficient and cost-effective approach to managing their critical observability data and reducing operational overhead.

Other United States companies recently funded

View all

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Edify logo

Edify

United States

$3.0M
2
Riverlution logo

Riverlution

United Kingdom

$40.4K
3
Goldenrod Therapeutics logo

Goldenrod Therapeutics

United States

$6.5M
4
HAGA.BIO logo

HAGA.BIO

Sweden

$2.3M
5
Hexigone Inhibitors logo

Hexigone Inhibitors

United Kingdom

$1.2M